QVT Financial LP - Q2 2016 holdings

$1.45 Billion is the total value of QVT Financial LP's 75 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 34.5% .

 Value Shares↓ Weighting
XBI SellSPDR SERIES TRUSTput$230,110,000
-20.5%
4,255,000
-24.0%
15.84%
-10.7%
 VERISIGN INCsdcv 3.250% 8/1$101,651,000
-2.0%
40,000,0000.0%7.00%
+10.0%
GS BuyGOLDMAN SACHS GROUP INC$78,129,000
-1.3%
525,838
+4.3%
5.38%
+10.8%
BuyMICROCHIP TECHNOLOGY INCsdcv 2.125%12/1$66,912,000
+112.9%
31,764,000
+101.5%
4.61%
+138.9%
 TAL ED GROUPnote 2.500% 5/1$57,491,000
+23.1%
24,000,0000.0%3.96%
+38.2%
QIHU BuyQIHOO 360 TECHNOLOGY CO LTDads$53,672,000
+33.8%
734,731
+38.4%
3.69%
+50.2%
 SHIP FINANCE INTERNATIONAL Lnote 3.250% 2/0$40,307,000
+8.2%
38,000,0000.0%2.77%
+21.4%
 CLOVIS ONCOLOGY INCnote 2.500% 9/1$30,998,000
+4.5%
43,295,0000.0%2.13%
+17.3%
 CTRIP COM INTL LTDnote 1.250%10/1$30,619,000
-5.1%
25,000,0000.0%2.11%
+6.5%
INTC SellINTEL CORP$30,504,000
-22.7%
930,004
-23.8%
2.10%
-13.3%
NewWELLPOINT INCnote 2.750%10/1$30,326,00016,500,000
+100.0%
2.09%
MMYT  MAKEMYTRIP LIMITED MAURITIUS$28,997,000
-17.2%
2,034,0240.0%2.00%
-7.1%
NYT  NEW YORK TIMES COcl a$28,168,000
-2.9%
2,327,8960.0%1.94%
+9.0%
SellINTEL CORPsdcv 12/1$25,841,000
-36.9%
20,000,000
-37.3%
1.78%
-29.2%
NAT SellNORDIC AMERICAN TANKERS LIMIput$25,176,000
-6.6%
1,812,500
-5.2%
1.73%
+4.9%
SellWESCO INTL INCdbcv 6.000% 9/1$24,524,000
-32.2%
13,550,000
-27.7%
1.69%
-23.9%
Z BuyZILLOW GROUP INCcl c cap stk$24,126,000
+118.7%
665,000
+43.0%
1.66%
+145.3%
XLRN  ACCELERON PHARMA INC$23,868,000
+28.8%
702,4100.0%1.64%
+44.5%
MU NewMICRON TECHNOLOGY INCcall$23,392,0001,700,000
+100.0%
1.61%
EQC  EQUITY COMWLTH$23,304,000
+3.2%
800,0000.0%1.60%
+15.9%
ZG BuyZILLOW GROUP INCcl a$21,990,000
+145.9%
600,000
+71.4%
1.51%
+176.3%
THC SellTENET HEALTHCARE CORP$21,959,000
-5.8%
794,457
-1.4%
1.51%
+5.7%
NRE BuyNORTHSTAR REALTY EUROPE CORP$21,910,000
-17.9%
2,368,606
+2.9%
1.51%
-7.9%
ATEX BuyPDVWIRELESS INC$17,702,000
-34.0%
902,599
+3.0%
1.22%
-25.9%
KANG SellIKANG HEALTHCARE GROUP INCsponsored adr$16,362,000
-22.5%
892,170
-7.6%
1.13%
-13.1%
 DHT HOLDINGS INCdebt 4.500%10/0$16,000,000
-2.5%
17,000,0000.0%1.10%
+9.3%
NAT  NORDIC AMERICAN TANKERS LIMI$15,711,000
-1.4%
1,131,1200.0%1.08%
+10.6%
WFC SellWELLS FARGO & CO NEW$15,619,000
-37.2%
330,000
-35.8%
1.08%
-29.5%
IBB  ISHARES TRnasdq biotec etf$15,483,000
-1.3%
60,1640.0%1.07%
+10.8%
AGEN SellAGENUS INC$14,899,000
-7.6%
3,678,707
-5.1%
1.02%
+3.6%
NewWEBMD HEALTH CORPnote 2.500% 1/3$13,892,00012,500,000
+100.0%
0.96%
NewCTRIP COM INTL LTDnote 1.000% 7/0$13,723,00013,000,000
+100.0%
0.94%
MRVL SellMARVELL TECHNOLOGY GROUP LTDord$13,448,000
-66.8%
1,411,162
-64.0%
0.93%
-62.7%
LBIO  LION BIOTECHNOLOGIES INC$12,946,000
+59.5%
1,598,3090.0%0.89%
+78.9%
CYTR SellCYTRX CORP$12,093,000
-18.9%
5,423,037
-7.3%
0.83%
-9.0%
JPM SellJPMORGAN CHASE & CO$11,185,000
-16.8%
180,000
-20.7%
0.77%
-6.6%
XLNX  XILINX INC$10,926,000
-2.7%
236,8550.0%0.75%
+9.1%
TNK BuyTEEKAY TANKERS LTDcl a$10,891,000
+62.9%
3,654,776
+100.7%
0.75%
+82.9%
ARWR NewARROWHEAD PHARMACEUTICALS IN$10,894,0002,047,782
+100.0%
0.75%
RLGY SellREALOGY HLDGS CORP$10,611,000
-26.5%
365,645
-8.6%
0.73%
-17.6%
TSM  TAIWAN SEMICONDUCTOR MFG LTDput$10,492,000
+0.1%
400,0000.0%0.72%
+12.3%
ICPT SellINTERCEPT PHARMACEUTICALS IN$10,450,000
+1.6%
73,243
-8.5%
0.72%
+13.9%
EPZM SellEPIZYME INC$9,953,000
-30.5%
971,946
-17.7%
0.68%
-22.0%
SCTY  SOLARCITY CORP$9,735,000
-2.6%
406,8160.0%0.67%
+9.3%
SCTY  SOLARCITY CORPput$9,716,000
-2.6%
406,0000.0%0.67%
+9.3%
AVXS  AVEXIS INC$8,958,000
+43.9%
242,7560.0%0.62%
+61.5%
BRFS  BRF SAsponsored adr$8,457,000
-2.0%
607,1120.0%0.58%
+10.0%
SRPT SellSAREPTA THERAPEUTICS INC$7,839,000
-10.7%
411,077
-8.6%
0.54%
+0.4%
BMRN SellBIOMARIN PHARMACEUTICAL INC$7,566,000
-13.7%
97,246
-8.5%
0.52%
-3.2%
XNCR  XENCOR INC$7,348,000
+41.5%
386,9250.0%0.51%
+59.1%
FIT NewFITBIT INCcl a$7,082,000579,502
+100.0%
0.49%
BLCM  BELLICUM PHARMACEUTICALS INC$6,583,000
+38.6%
507,9390.0%0.45%
+55.7%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$6,387,000
+0.3%
783,6450.0%0.44%
+12.5%
BGNE  BEIGENE LTDsponsored adr$5,066,000
+1.7%
170,0000.0%0.35%
+14.1%
 YY INCnote 2.250% 4/0$4,931,000
+1.1%
5,000,0000.0%0.34%
+13.4%
GLNG  GOLAR LNG LTD BERMUDA$4,654,000
-13.8%
300,2830.0%0.32%
-3.3%
MDGN SellMEDGENICS INC$4,557,000
+19.4%
848,800
-2.2%
0.31%
+34.2%
MFRM NewMATTRESS FIRM HLDG CORP$4,386,000130,738
+100.0%
0.30%
HALO SellHALOZYME THERAPEUTICS INC$4,319,000
-34.3%
500,449
-27.9%
0.30%
-26.3%
 ARRAY BIOPHARMA INCnote 3.000% 6/0$3,955,000
+7.3%
4,600,0000.0%0.27%
+20.4%
ZXAIY  CHINA ZENIX AUTO INTL LTDads$3,862,000
-28.9%
6,074,8050.0%0.27%
-20.1%
ASMB BuyASSEMBLY BIOSCIENCES INC$3,740,000
+22.7%
807,601
+9.0%
0.26%
+37.4%
RGNX  REGENXBIO INC$3,395,000
-25.0%
424,3680.0%0.23%
-15.8%
FRO NewFRONTLINE LTD$3,202,000408,341
+100.0%
0.22%
AKTX  AKARI THERAPEUTICS PLCsponsored adr$2,906,000
-9.3%
263,9210.0%0.20%
+1.5%
MRTX SellMIRATI THERAPEUTICS INC$2,783,000
-76.7%
509,750
-8.7%
0.19%
-73.8%
BLUE  BLUEBIRD BIO INC$2,554,000
+1.8%
59,0020.0%0.18%
+14.3%
FCSC  FIBROCELL SCIENCE INC$2,201,000
-50.0%
1,913,6620.0%0.15%
-44.1%
ADRO NewADURO BIOTECH INC$2,171,000191,954
+100.0%
0.15%
FPRX SellFIVE PRIME THERAPEUTICS INC$2,009,000
-70.9%
48,582
-71.5%
0.14%
-67.5%
OCRX  OCERA THERAPEUTICS INC$1,488,000
-39.2%
932,0860.0%0.10%
-32.0%
TCON  TRACON PHARMACEUTICALS INC$1,411,000
-38.8%
363,2920.0%0.10%
-31.2%
PTN SellPALATIN TECHNOLOGIES INC$1,248,000
-33.7%
4,039,374
-18.9%
0.09%
-25.2%
SRLP NewSPRAGUE RES LP$964,00039,979
+100.0%
0.07%
DNAI  PRONAI THERAPEUTICS INC$139,000
-70.6%
70,0000.0%0.01%
-65.5%
OCN ExitOCWEN FINL CORP$0-300,000
-100.0%
-0.04%
MTG ExitMGIC INVT CORP WIS$0-175,000
-100.0%
-0.08%
Z ExitZILLOW GROUP INCput$0-60,000
-100.0%
-0.09%
EJ ExitE HOUSE CHINA HLDGS LTDadr$0-416,438
-100.0%
-0.16%
DHT ExitDHT HOLDINGS INC$0-460,522
-100.0%
-0.16%
ALR ExitALERE INC$0-100,442
-100.0%
-0.31%
KKR ExitKKR & CO L P DEL$0-564,149
-100.0%
-0.51%
RY ExitROYAL BK CDA MONTREAL QUEput$0-150,000
-100.0%
-0.53%
W ExitWAYFAIR INCcl a$0-200,000
-100.0%
-0.53%
W ExitWAYFAIR INCput$0-200,000
-100.0%
-0.53%
ARWR ExitARROWHEAD RESH CORP$0-2,047,782
-100.0%
-0.60%
WLRH ExitWL ROSS HLDG CORP$0-1,000,000
-100.0%
-0.62%
VNET Exit21VIANET GROUP INCsponsored adr$0-525,189
-100.0%
-0.64%
NVGS ExitNAVIGATOR HOLDINGS LTD$0-650,769
-100.0%
-0.64%
ExitQIMONDA FIN LLCnote 6.750% 3/2$0-82,885,000
-100.0%
-0.79%
ExitVIPSHOP HLDGS LTDnote 1.500% 3/1$0-17,500,000
-100.0%
-1.08%
BLK ExitBLACKROCK INCput$0-60,000
-100.0%
-1.25%
YOKU ExitYOUKU TUDOU INCsponsored adr$0-805,499
-100.0%
-1.36%
PFF ExitISHARES TRput$0-820,000
-100.0%
-1.96%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAKEMYTRIP LIMITED MAURITIUS38Q3 20236.2%
NEW YORK TIMES CO34Q3 20232.6%
ACCELERON PHARMA INC32Q3 20212.8%
JPMORGAN CHASE & CO32Q3 20212.2%
SAREPTA THERAPEUTICS INC32Q3 20231.1%
BIOMARIN PHARMACEUTICAL INC32Q3 20230.5%
GOLDMAN SACHS GROUP INC30Q3 20235.4%
ACADIA PHARMACEUTICALS INC28Q3 20230.2%
WELLS FARGO CO NEW27Q4 20201.5%
NEXSTAR MEDIA GROUP INC26Q3 20233.4%

View QVT Financial LP's complete holdings history.

Latest significant ownerships (13-D/G)
QVT Financial LP Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MP Materials Corp. / DEMay 18, 20238,853,7125.0%
Grindrod Shipping Holdings Ltd.Sold outFebruary 14, 202200.0%
AEHR TEST SYSTEMSSold outFebruary 14, 202000.0%
Arbutus Biopharma CorpSold outJuly 12, 201900.0%
Axovant Gene Therapies Ltd.Sold outJuly 12, 201900.0%
Myovant Sciences Ltd.Sold outJuly 12, 201900.0%
Urovant Sciences Ltd.Sold outJuly 12, 201900.0%
Axovant Sciences Ltd.March 19, 2019105,952,38158.2%
Hunter Maritime Acquisition Corp.Sold outFebruary 14, 201900.0%
AGENUS INCFebruary 14, 20183,201,2633.2%

View QVT Financial LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-07
SC 13G/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
42023-10-02
1442023-09-28
13F-HR2023-08-14
SC 13D/A2023-05-18
13F-HR2023-05-15

View QVT Financial LP's complete filings history.

Compare quarters

Export QVT Financial LP's holdings